Last reviewed · How we verify

NCT06966791

Sexual Functıon in Young Women After Breast Cancer Surgery

Recruiting now Last updated 20 February 2026
What this trial tests

trial testing No intervention will be performed as part of this study. However, regardless of the study, all participants will have breast cancer surgery in Breast Cancer Surgery in 52 participants. Currently enrolling.

Timeline
30 December 2024
Primary endpoint
25 July 2025
25 July 2026

Quick facts

Lead sponsorATİYE KAŞ ÖZDEMİR
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment52
Start date30 December 2024
Primary completion25 July 2025
Estimated completion25 July 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

ATİYE KAŞ ÖZDEMİR

Who can join

Adults 18 to 50, female only, with Breast Cancer Surgery or Young Adult Females. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational study was to analyse sexual function in young women after breast cancer surgery. The main question it aims to answer is Sexual function in young women after breast cancer surgery changes during the one-year follow-up period. Participants will answer demographic information, Female Sexual Function Scale, Breast-Q and Body Perception Scale about their sexual function, quality of life and body perception. These will be recorded before surgery and repeated 6 weeks, 6 months and 1 year after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Breast Cancer Surgery

Currently open trials in the same condition.

Other ATİYE KAŞ ÖZDEMİR trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06966791.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing